A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer
Titel:
A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer
Auteur:
Krainer, Michael Tomek, Sandra Elandt, Katarzyna Horak, Peter Albrecht, Walter Eisenmenger, Michael Höltl, Wolfgang Schramek, Paul Stackl, Walter Zielinski, Christoph Reibenwein, Jochen